In late stage tumors, TGFβ usually functions as a tumor promoter, e.g., by stimulating EMT, i.e., trans-differentiation of epithelial cells to cells with more mesenchymal characteristics, and invasive and metastatic potential. Here, TGFB1 is linked to neoplasm.